Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Upstream Processing01:27

Upstream Processing

36
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
36
Production of Biopesticides01:18

Production of Biopesticides

57
Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...
57
Recombinant DNA01:09

Recombinant DNA

104.8K
Overview
104.8K
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

26
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
26

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emerging Non-Conventional Approaches in mRNA-LNP Formulation for Therapeutic Applications.

Pharmaceutics·2026
Same author

Special Issue: Novel Vaccines and Vaccine Technologies for Emerging Infections.

Vaccines·2026
Same author

Investigation on a Freeze-Drying Process for Long-Term Stability of mRNA-LNPs.

Vaccines·2026
Same author

Real-Time Monitoring of In Vitro Transcription for Production of mRNA Using Raman Spectroscopy.

Biotechnology and bioengineering·2026
Same author

Construction and Functional Characterization of a Heterologous Quorum Sensing Circuit in <i>Clostridium sporogenes</i>.

ACS synthetic biology·2025
Same author

AAV Assembled Capsids Are Produced in Cells Blocked From Cell Cycle Progression.

Biotechnology and bioengineering·2025

Related Experiment Video

Updated: Mar 26, 2026

Production of Recombinant PRMT Proteins using the Baculovirus Expression Vector System
08:57

Production of Recombinant PRMT Proteins using the Baculovirus Expression Vector System

Published on: July 17, 2021

8.5K

Recombinant Protein Production in Large-Scale Agitated Bioreactors Using the Baculovirus Expression Vector System.

Christine M Thompson1,2, Johnny Montes2, Marc G Aucoin3

  • 1Department of Chemical Engineering, Ecole Polytechnique de Montreal, 2500 Chemin de Polytechnique, Montreal, Canada.

Methods in Molecular Biology (Clifton, N.J.)
|January 29, 2016
PubMed
Summary

This chapter details recombinant protein production using the baculovirus expression vector system (BEVS) in large bioreactors. It covers batch process methods from cell growth to product recovery, including advanced monitoring and control strategies.

Keywords:
BaculovirusBioreactorFed-batchHigh cell densityInsect cellLarge-scaleLytic systemOn-line monitoringRecombinant protein expressionSerum-free medium

More Related Videos

Production and Purification of Baculovirus for Gene Therapy Application
06:11

Production and Purification of Baculovirus for Gene Therapy Application

Published on: April 9, 2018

16.1K
Modifying Baculovirus Expression Vectors to Produce Secreted Plant Proteins in Insect Cells
09:14

Modifying Baculovirus Expression Vectors to Produce Secreted Plant Proteins in Insect Cells

Published on: August 20, 2018

12.4K

Related Experiment Videos

Last Updated: Mar 26, 2026

Production of Recombinant PRMT Proteins using the Baculovirus Expression Vector System
08:57

Production of Recombinant PRMT Proteins using the Baculovirus Expression Vector System

Published on: July 17, 2021

8.5K
Production and Purification of Baculovirus for Gene Therapy Application
06:11

Production and Purification of Baculovirus for Gene Therapy Application

Published on: April 9, 2018

16.1K
Modifying Baculovirus Expression Vectors to Produce Secreted Plant Proteins in Insect Cells
09:14

Modifying Baculovirus Expression Vectors to Produce Secreted Plant Proteins in Insect Cells

Published on: August 20, 2018

12.4K

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Bioprocess Engineering

Background:

  • The baculovirus expression vector system (BEVS) is a powerful tool for recombinant protein production.
  • Large-scale production in agitated bioreactors presents unique challenges for BEVS applications.

Purpose of the Study:

  • To provide a comprehensive overview of the methods for large-scale recombinant protein production using BEVS in agitated bioreactors.
  • To detail the critical stages of a batch process for efficient protein recovery.

Main Methods:

  • Host cell cultivation and virus stock amplification and quantification.
  • Bioreactor preparation, operation, and the infection process.
  • Product harvesting and primary separation techniques, including on-line monitoring and control.

Main Results:

  • Detailed methodologies for each stage of the BEVS batch process are presented.
  • The importance of advanced on-line monitoring and bioreactor control for process success is highlighted.

Conclusions:

  • Successful large-scale recombinant protein production using BEVS requires careful optimization of each process step.
  • Integration of advanced monitoring and control enhances overall process efficiency and product yield.